Product Information

BRIMONIDINE TARTRATE 0.1% DROP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $8.1556 per ML under NDC 62332074905. Its NADAC has been published 143 times since Feb 21, 2024.

FDA first approved this application on Aug 1, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE TARTRATE 0.1% DROP

Brimonidine Tartrate
$8.1556per ML

Strength

1 mg/mL

NDC

62332074905

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

BRIMONIDINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA216909

FDA Approved

8/1/2023

TE Code

AB

On Market Since

8/1/2023

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for BRIMONIDINE TARTRATE 0.1% DROP has been published 143 times since Feb 21, 2024, and over the history we have for it it has declined 73.7%. The table below summarizes its recorded NADAC range and movement.

Current price$8.1556 per ML
All-time high$30.9975 (Mar 13, 2024)
All-time low$8.1556 (Oct 21, 2026)
52-week high$14.2000
52-week low$8.1556
Median price$15.2619
Average price$15.5489
Largest weekly change-35.2% (Apr 17, 2024)
Weeks tracked143
Tracking sinceFeb 21, 2024

Price History

1W

0.0%

1M

-10.0%

3M

-19.1%

6M

-21.4%

1Y

-43.3%

3Y

N/A

5Y

N/A

All

-73.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 25%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRIMONIDINE TARTRATE 0.1% DROP?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE TARTRATE 0.1% DROP, manufactured by Alembic Pharmaceuticals Inc., is $8.1556 per ML (NDC 62332074905), effective Nov 11, 2026.

How has the price of BRIMONIDINE TARTRATE 0.1% DROP changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE TARTRATE 0.1% DROP has declined 73.7%. It has been tracked across 143 weekly CMS publications since Feb 21, 2024.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE TARTRATE 0.1% DROP?

Since Feb 21, 2024, the NADAC for BRIMONIDINE TARTRATE 0.1% DROP has ranged from a low of $8.1556 (Oct 21, 2026) to a high of $30.9975 (Mar 13, 2024), with a median of $15.2619 per ML.

Are there cheaper alternatives to BRIMONIDINE TARTRATE 0.1% DROP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE TARTRATE 0.1% DROP, is $6.0954 per ML — about 25% below BRIMONIDINE TARTRATE 0.1% DROP.

Who manufactures BRIMONIDINE TARTRATE 0.1% DROP?

BRIMONIDINE TARTRATE 0.1% DROP (NDC 62332074905) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.